MICHELLE BAILEY: Open Payments
NPI 1841940673 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 27 payments from 8 companies in 2025. Trend: 2023 $981 · 2024 $1,253 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $208 |
| Organon LLC | 1 | $92 |
| Lilly USA, LLC | 3 | $48 |
| Novo Nordisk Inc | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, VTAMA, MOUNJARO, QULIPTA, SPRAVATO, SKYRIZI, JARDIANCE, Ozempic.
Industry payments across OH — which companies pay providers there.
